Related Experiment Videos
[Immunology in clinical practice. VII. Psoriasis]
1Afd. Huidziekten, Academisch Medisch Centrum, Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|April 29, 1998
Summary
Psoriasis is an epidermal disorder caused by T cell and keratinocyte interactions. Therapies targeting T cell activity, like cyclosporine, show success in treating severe psoriasis.
Area of Science:
- Immunodermatology
- Epidermal Biology
- Cellular Pathogenesis
Context:
- Psoriasis pathogenesis is complex, involving epidermal hyperproliferation.
- Abnormal interactions between T cells and basal keratinocytes are implicated.
- Current understanding points to immune system dysregulation.
Purpose:
- To present a novel hypothesis on psoriasis pathogenesis.
- To highlight the role of T cell-keratinocyte interactions.
- To underscore the therapeutic implications of targeting T cell activity.
Summary:
- Psoriasis is hypothesized as an epidermal hyperproliferative disorder.
- This condition arises from aberrant cross-talk between T lymphocytes and basal stem cell keratinocytes.
- Systemic cyclosporine's efficacy in severe psoriasis exemplifies successful T cell-targeted therapy.
Impact:
- Suggests new therapeutic strategies focusing on T cell modulation.
- Anticipates advancements in immunogenetics and immunodermatology to elucidate pathogenic pathways.
- Provides a framework for understanding psoriasis as an immune-mediated epidermal disease.